A clear goal: every child desired.
Choice started with a simple conviction: every child should be desired. For that, contraception has to be something you can switch on and off, without hormones and without having to think about it every day. Peter van de Graaf, an industrial designer with thirty years in medical product development, set out to build exactly that, in Eindhoven, on the former Philips site.

Gynaecologists and engineers.
A scientific advisory board with experience in tubal implants, women's health innovation, reproductive biology and medical device regulation.
Who we work with.
Research institutes, hospitals, funders and specialised medtech companies, each covering part of the chain from fine mechanics to clinical studies.
Protected where it matters.
Three patent families cover the system as a whole, the valve and its mode switch, with patents granted in Europe and the United States. How the valve, stent and endoscope are made is kept as know-how.
Press enquiries.
For interviews, images and background information, please contact Peter van de Graaf.
- May 2026
- Het Financieele Dagblad · Klepjes in eileiders als ultiem anticonceptiemiddel
- June 2025
- NPO Radio 1 · Revolutionaire anticonceptie zonder hormonen
- May 2025
- de Volkskrant · Revolutionaire nieuwe vorm van anticonceptie
We are preparing the next round.
To take Choice through its first studies in women. Investor materials are shared under confidentiality.








